New drug shows promise for lung scarring disease in small trial
Disease control
Completed
This study tested an experimental drug called MN-001 in 15 people with moderate to severe idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing problems. For 6 months, some participants received the drug and others received a placebo (a dummy pill…
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated May 15, 2026 11:55 UTC